Practice variation in the re-initiation of dofetilide: An observational study

Mohit K. Turagam, Muhammad R. Afzal, Madhu Reddy, Jayasree Pillarisetti, Madhav Lavu, Donita Atkins, Courtney Jeffrey, Katie Christensen, Rhea Pimentel, Raghuveer Dendi, James Vacek, Jodi Hurwitz, Luigi Di Biase, Andrea Natale, Dhanunjaya Lakkireddy

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Background Dofetilide is a class III antiarrhythmic drug that has been reported to be safe and efficacious in the treatment of atrial dysrhythmias with a known initial risk of QT prolongation and torsades de pointes (TdP). As a result, the Federal Drug Administration (FDA) mandated in-hospital dofetilide initiation and adherence to a common dosing protocol. However, there is a lack of clarity on how to manage dofetilide re-initiation. Methods An observational survey was performed including 347 cardiologists in the United States and worldwide to evaluate the deviations from approved manufacturer's protocol during dofetilide initiation and re-initiation among practicing cardiologists. Results Most practicing cardiologists were cautious about outpatient dofetilide use and adhered to the manufacturer's in-patient dofetilide protocol during de-novo initiation and reported low incidence of TdP in clinical practice. There were substantial differences among practicing cardiologists with deviation from the manufacturer's protocol during re-initiation of dofetilide. About 21% cardiologists always admitted patients to the hospital while 37% admitted patients < 10% of the time for dofetilide re-initiation. Only 4% reported major adverse events with outpatient dofetilide re-initiation. There was also wide variation regarding monitoring of electrolytes and QT interval as an outpatient with dofetilide. Conclusion There is significant practice pattern variation in the use of dofetilide for the management of AF. This degree of variation noted is concerning and is a reflection of the current lack of substantial clinical evidence in the re-initiation dofetilide protocol to help direct the provider.

Original languageEnglish (US)
Pages (from-to)221-225
Number of pages5
JournalInternational Journal of Cardiology
StatePublished - Jun 1 2017


  • Antiarrhythmic drug
  • Atrial fibrillation
  • Dofetilide
  • Practice pattern
  • Survey
  • Tikosyn

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Practice variation in the re-initiation of dofetilide: An observational study'. Together they form a unique fingerprint.

Cite this